Sale!

Criggler Najjar Syndrome Test Cost

Original price was: 7,200 د.إ.Current price is: 5,400 د.إ.

-25%

Criggler Najjar Syndrome Test is a specialized diagnostic assessment aimed at detecting Crigler-Najjar syndrome, a rare genetic disorder characterized by an inability to properly process bilirubin, leading to jaundice and potentially severe neurological damage if not managed correctly. This condition arises due to mutations in the UGT1A1 gene, which is crucial for bilirubin breakdown.

The test, available at DNA Labs UAE, involves a detailed analysis of the patient’s DNA to identify mutations in the UGT1A1 gene. This genetic testing is critical for accurate diagnosis, allowing for tailored management and treatment plans to prevent complications associated with the syndrome. The cost of the Criggler Najjar Syndrome Test at DNA Labs UAE is 5400 AED, reflecting the sophisticated technology and expertise required to perform this specialized genetic analysis. Early diagnosis through this test can significantly improve the quality of life for individuals with Criggler-Najjar syndrome by facilitating early interventions.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Criggler Najjar Syndrome Test

Test Name: Criggler Najjar Syndrome Test

Components: EDTA Vacutainer (2ml)

Price: 5400.0 AED

Sample Condition: Peripheral Blood

Report Delivery: 7-8 days

Method: Sanger Sequencing

Test Type: Genetics

Doctor: Gynecologist

Test Department:

Pre Test Information: Criggler Najjar Syndrome can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

Criggler Najjar Syndrome (CNS) is a rare genetic disorder that affects the liver’s ability to process bilirubin, a substance produced when red blood cells break down. Bilirubin builds up in the blood and causes jaundice, a yellowing of the skin and eyes.

There are two types of CNS: type 1 and type 2. Type 1 is more severe and occurs when the liver is unable to process any bilirubin. This can lead to brain damage, seizures, and even death. Type 2 is less severe and occurs when the liver can process some bilirubin but not enough to prevent jaundice.

Treatment for CNS involves phototherapy, which uses special lights to break down bilirubin in the blood, and medication to help the liver process bilirubin. In severe cases, a liver transplant may be necessary.

CNS is an inherited disorder and is caused by mutations in the UGT1A1 gene. It is typically diagnosed in infancy or childhood. There is currently no cure for CNS, but with proper management, individuals with the condition can lead relatively normal lives.

Test Name Criggler Najjar Syndrome Test
Components EDTA Vacutainer (2ml)
Price 5400.0 AED
Sample Condition Peripheral Blood
Report Delivery 7-8 days
Method Sanger Sequencing
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information Criggler Najjar Syndrome can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Criggler Najjar Syndrome (CNS) is a rare genetic disorder that affects the liver’s ability to process bilirubin, a substance produced when red blood cells break down. Bilirubin builds up in the blood and causes jaundice, a yellowing of the skin and eyes.

There are two types of CNS: type 1 and type 2. Type 1 is more severe and occurs when the liver is unable to process any bilirubin. This can lead to brain damage, seizures, and even death. Type 2 is less severe and occurs when the liver can process some bilirubin but not enough to prevent jaundice.

Treatment for CNS involves phototherapy, which uses special lights to break down bilirubin in the blood, and medication to help the liver process bilirubin. In severe cases, a liver transplant may be necessary.

CNS is an inherited disorder and is caused by mutations in the UGT1A1 gene. It is typically diagnosed in infancy or childhood. There is currently no cure for CNS, but with proper management, individuals with the condition can lead relatively normal lives.